Ringful Health is the leader in providing patient-centered and evidence-based teamwork solutions to help hospitals and communities improve healthcare outcome, patient safety, and reduce cost through mobile and decision support technologies.
Michael Yuan, PhD, CEO
Michael Yuan is a recognized expert in mobile and Internet software development. He published 5 books and over 40 articles in this area. Michael has extensive experience managing startup teams, building developer communities, and delivering consumer software. Prior to Ringful, Michael worked in product and technology leadership roles in JBoss, Red Hat, and eZee.
Kim Johnson, COO
Mr. Johnson is focused on non-profit outreach and government grants. He has over 25 years in senior management positions with media and technology companies including Primestar Partners which grew from a start up operation to over $1 Billion in annual service revenues. His expertise includes building scalable service operations, distribution strategy, and deploying consumer electronics technologies.
Ivelin Ivanov, CTO
Ivelin is an active member of the HIT community, severing on the board of directors of HIMSS Austin. Ivelin brings 15 years of international software development and product management experience. Ivelin has 7 years of experience with leading software architecture and design at established companies such as Red Hat Inc., JBoss Inc. and BMC Software Inc. Throughout his professional career, Ivelin has bootstrapped 4 and joined 3 early stage technology companies, most recently JBoss and Mobicents. He is a recognized contributor and project leader in the Open Source Software community.
Elizabeth Vandewater, PhD, Chief Scientist
Dr. Vandewater is Professor of Health Promotions at the University of Texas School of Public Health. She is a world renowned researcher on technology impact of public health, and serves as the lead methodologist in several large scale clinical studies. She designs and directs Ringful Health’s clinical studies to collect evidence on the efficacy of our approaches and products.
Koushik Shaw, MD, Chief Medical Officer
Dr. Shaw is a Urologist, Renal Transplant Surgeon, and book author. He is a leader in robotic and oncologic surgery and leads one of the few teams in central Texas that performs complex robotics cases involving reconstructive and oncologic work as well as being involved in teaching and proctoring these cases to surgeons new in the field. Dr. Shaw frequently appears on TV to educate the public about prostate, bladder, and kidney health, and is active in health care education to his patients as well as in routine community seminars. He brings in medical expertise to the team to help Ringful create healthcare apps that are used to optimize the doctor-patient relationship.
Chun-su Yuan, MD, PhD
Dr. Yuan is the Cryus Tang Professor in the Pritzker School of Medicine at the University of Chicago. He has published over 150 research papers on new drug development, and is a practicing physician. Dr. Yuan led the preclinical and early clinical trials of methylnaltrexone, which resulted in FDA approval in 2008 for Relistor and is now available in over 30 countries. Dr. Yuan is also a physician consultant for major pharmaceutical companies, venture firms, and law firms.
Steve Andrade is a seasoned executive with over 20 years of operating experience specializing in the application of technology to improve human health. He has led the growth and innovation at businesses ranging from early stage start-ups to large diversified corporations and across the technology, life sciences and health care industries. Steve was Group Vice President and General Manager at Siebel Systems where he built the life sciences business into a global market leader with profitable double digit growth. After the acquisition of Siebel Systems, he led Oracle Corporation’s global Health Sciences Business Unit as Senior Vice President and General Manager. Later, Steve was the CEO at DecisionView where he led a successful turnaround of that early stage clinical technology company. Steve continues to help drive the convergence of technology, healthcare and life sciences as an advisory board member of several companies.